Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

This is the meat:

“The data from the studies affirm that Kevetrin may be useful in a new tumor type, in addition to the other indications that we are studying. Kevetrin has delivered robust results against all indications tested to date. Cellceutix’s strategy is to have multiple trials ongoing against multiple cancer types concurrently. We are conducting testing against several more cancers to delineate the quickest path to market to build corporate and shareholder value.”

Since he refers to "data from the studies" can we assume he also includes human testing in that data? If so, the "robust results" might be signaling they have data that aligns with animal testing including efficacy at low doses.